Aryatech Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 2 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
About Aryatech Pharma
Aryatech Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 December 2022 (Two years and two months 15 days old ). Its registered office is in Dehradun, Uttarakhand, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.00 Cr.
Sanjeev Sharma and Sarita Tiwari serve as directors at the Company.
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909UR2022PTC014976
- Company No.
014976
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2022
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Aryatech Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Sharma  | Director | 12-Dec-2022 | Current |
| Sarita Tiwari | Director | 12-Dec-2022 | Current |
Financial Performance of Aryatech Pharma.
Aryatech Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Aryatech Pharma?
Unlock access to Aryatech Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Niharith Pharma Private LimitedSarita Tiwari is a mutual person
Fedrox Formulation LlpSanjeev Sharma is a mutual person
- Clove Aroma & Herbals Private Limited
Sanjeev Sharma is a mutual person
- Aryatech Lifesciences Private Limited
Sanjeev Sharma is a mutual person
- Gurukulherbal India Private Limited
Sanjeev Sharma is a mutual person
Charges (Loans)
₹20.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 May 2023 | Others | ₹2.00 Cr | Open |
How Many Employees Work at Aryatech Pharma?
Unlock and access historical data on people associated with Aryatech Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aryatech Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aryatech Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.